Keywords
Last Name
Institution

RICHARD A. BOND

TitleProfessor
InstitutionUniversity of Houston College of Pharmacy
DepartmentPharmacological & Pharmaceutical Sciences
Address542 Science and Research Building 2
Houston TX 77204-5037
vCardDownload vCard

    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Forkuo GS, Kim H, Thanawala VJ, Al-Sawalha N, Valdez D, Joshi R, Parra S, Pera T, Gonnella PA, Knoll BJ, Walker JK, Penn RB, Bond RA. Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by ?2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice. Am J Respir Cell Mol Biol. 2016 Aug; 55(2):234-42. PMID: 26909542; PMCID: PMC4979368 [Available on 08/01/17].
    2. Bond RA, Thanawala VJ, Parra S, Leff P. Differences in asthma study models and the effectiveness of ?2 -adrenoceptor ligands: response to Lipworth et al. Br J Pharmacol. 2016 Jan; 173(1):250-1. PMID: 26687674.
      View in: PubMed
    3. Knight JM, Mak G, Shaw J, Porter P, McDermott C, Roberts L, You R, Yuan X, Millien VO, Qian Y, Song LZ, Frazier V, Kim C, Kim JJ, Bond RA, Milner JD, Zhang Y, Mandal PK, Luong A, Kheradmand F, McMurray JS, Corry DB. Long-Acting Beta Agonists Enhance Allergic Airway Disease. PLoS One. 2015; 10(11):e0142212. PMID: 26605551.
      View in: PubMed
    4. Thanawala VJ, Valdez DJ, Joshi R, Forkuo GS, Parra S, Knoll BJ, Bouvier M, Leff P, Bond RA. Beta-blockers have differential effects on the murine asthma phenotype. Br J Pharmacol. 2015 Jul 24. PMID: 26211486.
      View in: PubMed
    5. Al-Sawalha N, Pokkunuri I, Omoluabi O, Kim H, Thanawala VJ, Hernandez A, Bond RA, Knoll BJ. Epinephrine Activation of the ß2-Adrenoceptor Is Required for IL-13-Induced Mucin Production in Human Bronchial Epithelial Cells. PLoS One. 2015; 10(7):e0132559. PMID: 26161982.
      View in: PubMed
    6. Curtis MJ, Bond RA, Spina D, Ahluwalia A, Alexander SP, Giembycz MA, Gilchrist A, Hoyer D, Insel PA, Izzo AA, Lawrence AJ, MacEwan DJ, Moon LD, Wonnacott S, Weston AH, McGrath JC. Experimental design and analysis and their reporting: new guidance for publication in BJP. Br J Pharmacol. 2015 Jul; 172(14):3461-71. PMID: 26114403.
      View in: PubMed
    7. Michel MC, Seifert R, Bond RA. Dynamic bias and its implications for GPCR drug discovery. Nat Rev Drug Discov. 2014 Nov; 13(11):869. PMID: 25323926.
      View in: PubMed
    8. Geng C, Rajapakshe K, Shah SS, Shou J, Eedunuri VK, Foley C, Fiskus W, Rajendran M, Chew SA, Zimmermann M, Bond R, He B, Coarfa C, Mitsiades N. Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer. Cancer Res. 2014 Oct 1; 74(19):5631-43. PMID: 25274033; PMCID: PMC4209379.
    9. Thanawala VJ, Forkuo GS, Stallaert W, Leff P, Bouvier M, Bond R. Ligand bias prevents class equality among beta-blockers. Curr Opin Pharmacol. 2014 Jun; 16:50-7. PMID: 24681351; PMCID: PMC4065631.
    10. Bond RA. The intrinsic bias of generalizations. Am J Respir Crit Care Med. 2014 Feb 1; 189(3):359. PMID: 24484333; PMCID: PMC3977730.
    11. Penn RB, Bond RA, Walker JK. GPCRs and arrestins in airways: implications for asthma. Handb Exp Pharmacol. 2014; 219:387-403. PMID: 24292841; PMCID: PMC4429126.
    12. Forkuo GS, Thanawala VJ, Al-Sawalha N, Bond RA, Walker JK. Reply: Adverse effects of long-acting beta-agonists on airway hyperresponsiveness. Am J Respir Cell Mol Biol. 2013 Sep; 49(3):502. PMID: 23991664; PMCID: PMC3824060.
    13. Vollert C, Forkuo GS, Bond RA, Eriksen JL. Chronic treatment with DCPCX, an adenosine A(1) antagonist, worsens long-term memory. Neurosci Lett. 2013 Aug 26; 548:296-300. PMID: 23748072; PMCID: PMC3722854.
    14. Geng C, He B, Xu L, Barbieri CE, Eedunuri VK, Chew SA, Zimmermann M, Bond R, Shou J, Li C, Blattner M, Lonard DM, Demichelis F, Coarfa C, Rubin MA, Zhou P, O'Malley BW, Mitsiades N. Prostate cancer-associated mutations in speckle-type POZ protein (SPOP) regulate steroid receptor coactivator 3 protein turnover. Proc Natl Acad Sci U S A. 2013 Apr 23; 110(17):6997-7002. PMID: 23559371; PMCID: PMC3637757.
    15. Nguyen LP, Singh B, Okulate AA, Alfaro VY, Tuvim MJ, Dickey BF, Bond RA. Complementary anti-inflammatory effects of a ?-blocker and a corticosteroid in an asthma model. Naunyn Schmiedebergs Arch Pharmacol. 2012 Feb; 385(2):203-10. PMID: 21964666.
      View in: PubMed
    16. Walker JK, Penn RB, Hanania NA, Dickey BF, Bond RA. New perspectives regarding ?(2) -adrenoceptor ligands in the treatment of asthma. Br J Pharmacol. 2011 May; 163(1):18-28. PMID: 21175591; PMCID: PMC3085865.
    17. Peng H, Bond RA, Knoll BJ. The effects of acute and chronic nadolol treatment on ?2AR signaling in HEK293 cells. Naunyn Schmiedebergs Arch Pharmacol. 2011 Feb; 383(2):209-16. PMID: 21225244.
      View in: PubMed
    18. Hanania NA, Mannava B, Franklin AE, Lipworth BJ, Williamson PA, Garner WJ, Dickey BF, Bond RA. Response to salbutamol in patients with mild asthma treated with nadolol. Eur Respir J. 2010 Oct; 36(4):963-5. PMID: 20889466.
      View in: PubMed
    19. Dickey BF, Walker JK, Hanania NA, Bond RA. beta-Adrenoceptor inverse agonists in asthma. Curr Opin Pharmacol. 2010 Jun; 10(3):254-9. PMID: 20399707; PMCID: PMC2905467.
    20. Hanania NA, Dickey BF, Bond RA. Clinical implications of the intrinsic efficacy of beta-adrenoceptor drugs in asthma: full, partial and inverse agonism. Curr Opin Pulm Med. 2010 Jan; 16(1):1-5. PMID: 19887938; PMCID: PMC2855430.
    21. Nguyen LP, Lin R, Parra S, Omoluabi O, Hanania NA, Tuvim MJ, Knoll BJ, Dickey BF, Bond RA. Beta2-adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc Natl Acad Sci U S A. 2009 Feb 17; 106(7):2435-40. PMID: 19171883; PMCID: PMC2650174.
    22. Nguyen LP, Omoluabi O, Parra S, Frieske JM, Clement C, Ammar-Aouchiche Z, Ho SB, Ehre C, Kesimer M, Knoll BJ, Tuvim MJ, Dickey BF, Bond RA. Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model. Am J Respir Cell Mol Biol. 2008 Mar; 38(3):256-62. PMID: 18096872; PMCID: PMC2258446.
    23. Hanania NA, Singh S, El-Wali R, Flashner M, Franklin AE, Garner WJ, Dickey BF, Parra S, Ruoss S, Shardonofsky F, O'Connor BJ, Page C, Bond RA. The safety and effects of the beta-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm Pharmacol Ther. 2008; 21(1):134-41. PMID: 17703976; PMCID: PMC2254137.
    24. Lin R, Peng H, Nguyen LP, Dudekula NB, Shardonofsky F, Knoll BJ, Parra S, Bond RA. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther. 2008; 21(1):115-24. PMID: 17689122; PMCID: PMC2775056.
    25. Bond RA, Spina D, Parra S, Page CP. Getting to the heart of asthma: can "beta blockers" be useful to treat asthma? Pharmacol Ther. 2007 Sep; 115(3):360-74. PMID: 17681610.
      View in: PubMed
    26. Parra S, Bond RA. Inverse agonism: from curiosity to accepted dogma, but is it clinically relevant? Curr Opin Pharmacol. 2007 Apr; 7(2):146-50. PMID: 17284360.
      View in: PubMed
    27. Dudekula N, Arora V, Callaerts-Vegh Z, Bond RA. The temporal hormesis of drug therapies. Dose Response. 2005; 3(3):414-24. PMID: 18648614; PMCID: PMC2475944.
    28. Bond RA, Ijzerman AP. Recent developments in constitutive receptor activity and inverse agonism, and their potential for GPCR drug discovery. Trends Pharmacol Sci. 2006 Feb; 27(2):92-6. PMID: 16406086.
      View in: PubMed
    29. Bond RA. A proposal for a national program reporting beneficial drug responses, analogous to the existing program to detect adverse drug responses. Med Hypotheses. 2006; 66(1):10-3. PMID: 16198061.
      View in: PubMed
    30. Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H. Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci. 2004 Jul; 25(7):358-65. PMID: 15219978.
      View in: PubMed
    31. Callaerts-Vegh Z, Evans KL, Dudekula N, Cuba D, Knoll BJ, Callaerts PF, Giles H, Shardonofsky FR, Bond RA. Effects of acute and chronic administration of beta-adrenoceptor ligands on airway function in a murine model of asthma. Proc Natl Acad Sci U S A. 2004 Apr 6; 101(14):4948-53. PMID: 15069206; PMCID: PMC387354.
    32. Xiao RP, Zhang SJ, Chakir K, Avdonin P, Zhu W, Bond RA, Balke CW, Lakatta EG, Cheng H. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation. 2003 Sep 30; 108(13):1633-9. PMID: 12975249.
      View in: PubMed
    33. Flesch M, Höper A, Dell'Italia L, Evans K, Bond R, Peshock R, Diwan A, Brinsa TA, Wei CC, Sivasubramanian N, Spinale FG, Mann DL. Activation and functional significance of the renin-angiotensin system in mice with cardiac restricted overexpression of tumor necrosis factor. Circulation. 2003 Aug 5; 108(5):598-604. PMID: 12874189.
      View in: PubMed
    34. Callaerts-Vegh Z, Evans KL, Shipley GL, Davies PJ, Cuba DL, Gurji HA, Giles H, Bond RA. Effects of different beta adrenoceptor ligands in mice with permanent occlusion of the left anterior descending coronary artery. Br J Pharmacol. 2003 Apr; 138(8):1505-16. PMID: 12721106; PMCID: PMC1573808.
    35. Evans KL, Bond RA, Corry DB, Shardonofsky FR. Frequency dependence of respiratory system mechanics during induced constriction in a murine model of asthma. J Appl Physiol (1985). 2003 Jan; 94(1):245-52. PMID: 12486022.
      View in: PubMed
    36. Bond RA. Can intellectualism stifle scientific discovery? Nat Rev Drug Discov. 2002 Oct; 1(10):825-9. PMID: 12360260.
      View in: PubMed
    37. Liu X, Callaerts-Vegh Z, Evans KL, Bond RA. Chronic infusion of beta-adrenoceptor antagonist and inverse agonists decreases elevated protein kinase A activity in transgenic mice with cardiac-specific overexpression of human beta 2-adrenoceptor. J Cardiovasc Pharmacol. 2002 Sep; 40(3):448-55. PMID: 12198331.
      View in: PubMed
    38. Bond RA. Is paradoxical pharmacology a strategy worth pursuing? Trends Pharmacol Sci. 2001 Jun; 22(6):273-6. PMID: 11395153.
      View in: PubMed
    39. Franceschini D, Orr-Urtreger A, Yu W, Mackey LY, Bond RA, Armstrong D, Patrick JW, Beaudet AL, De Biasi M. Altered baroreflex responses in alpha7 deficient mice. Behav Brain Res. 2000 Aug; 113(1-2):3-10. PMID: 10942027.
      View in: PubMed
    40. Nagaraja S, Iyer S, Liu X, Eichberg J, Bond RA. Treatment with inverse agonists enhances baseline atrial contractility in transgenic mice with chronic beta2-adrenoceptor activation. Br J Pharmacol. 1999 Jul; 127(5):1099-104. PMID: 10455254; PMCID: PMC1566118.
    41. Clarke WP, Bond RA. The elusive nature of intrinsic efficacy. Trends Pharmacol Sci. 1998 Jul; 19(7):270-6. PMID: 9703760.
      View in: PubMed
    42. Milligan G, Bond RA. Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci. 1997 Dec; 18(12):468-74. PMID: 9458695.
      View in: PubMed
    43. Gürdal H, Bond RA, Johnson MD, Friedman E, Onaran HO. An efficacy-dependent effect of cardiac overexpression of beta2-adrenoceptor on ligand affinity in transgenic mice. Mol Pharmacol. 1997 Aug; 52(2):187-94. PMID: 9271340.
      View in: PubMed
    44. Samama P, Bond RA, Rockman HA, Milano CA, Lefkowitz RJ. Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc Natl Acad Sci U S A. 1997 Jan 7; 94(1):137-41. PMID: 8990174; PMCID: PMC19258.
    45. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J, Lefkowitz RJ, Caron MG, Giros B. Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc Natl Acad Sci U S A. 1996 Nov 12; 93(23):12974-9. PMID: 8917529; PMCID: PMC24031.
    46. Nagao T, Nakashima M, Smart FW, Bond RA, Morrison KJ, Vanhoutte PM. Potentiation of endothelium-dependent hyperpolarization to serotonin by dietary intake of NC 020, a defined fish oil, in the porcine coronary artery. J Cardiovasc Pharmacol. 1995 Nov; 26(5):679-81. PMID: 8637179.
      View in: PubMed
    47. Koch WJ, Rockman HA, Samama P, Hamilton RA, Bond RA, Milano CA, Lefkowitz RJ. Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science. 1995 Jun 2; 268(5215):1350-3. PMID: 7761854.
      View in: PubMed
    48. Bond RA, Leff P, Johnson TD, Milano CA, Rockman HA, McMinn TR, Apparsundaram S, Hyek MF, Kenakin TP, Allen LF, et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature. 1995 Mar 16; 374(6519):272-6. PMID: 7885448.
      View in: PubMed
    49. Milano CA, Allen LF, Dolber PC, Johnson TD, Rockman HA, Bond RA, Lefkowitz RJ. Marked enhancement in myocardial function resulting from overexpression of a human beta-adrenergic receptor gene. J Thorac Cardiovasc Surg. 1995 Feb; 109(2):236-41. PMID: 7853876.
      View in: PubMed
    50. Milligan G, Bond RA, Lee M. Inverse agonism: pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci. 1995 Jan; 16(1):10-3. PMID: 7732597.
      View in: PubMed
    51. Hieble JP, Bond RA. New directions in adrenoceptor pharmacology. Trends Pharmacol Sci. 1994 Nov; 15(11):397-9. PMID: 7855898.
      View in: PubMed
    52. Milano CA, Dolber PC, Rockman HA, Bond RA, Venable ME, Allen LF, Lefkowitz RJ. Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):10109-13. PMID: 7937846; PMCID: PMC44967.
    53. Milano CA, Allen LF, Rockman HA, Dolber PC, McMinn TR, Chien KR, Johnson TD, Bond RA, Lefkowitz RJ. Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science. 1994 Apr 22; 264(5158):582-6. PMID: 8160017.
      View in: PubMed
    54. Boulanger CM, Hughes H, Bond RA, Rafla E, Vanhoutte PM. Effects of S9977 on adrenergic neurotransmission. Gen Pharmacol. 1993 Mar; 24(2):429-34. PMID: 8387054.
      View in: PubMed
    55. Schini VB, Bond R, Gao Y, Illiano S, Junquero DC, Mombouli JV, Nagao T, Smart F, Vanhoutte PM. The sydnonimine C87-3754 evokes endothelium-independent relaxations and prevents endothelium-dependent contractions in blood vessels of the dog. J Cardiovasc Pharmacol. 1993; 22 Suppl 7:S10-6. PMID: 7504762.
      View in: PubMed
    56. Bond RA, Vanhoutte PM. Interaction of tertatolol at the "atypical" or beta 3-adrenoceptor in guinea-pig ileum. Gen Pharmacol. 1992 Mar; 23(2):171-6. PMID: 1353468.
      View in: PubMed
    57. Gao YS, Nagao T, Bond RA, Janssens WJ, Vanhoutte PM. Nebivolol induces endothelium-dependent relaxations of canine coronary arteries. J Cardiovasc Pharmacol. 1991 Jun; 17(6):964-9. PMID: 1714022.
      View in: PubMed
    58. Blue DR, Bond RA, Adham N, Delmendo R, Michel AD, Eglen RM, Whiting RL, Clarke DE. Antagonist characterization of atypical beta adrenoceptors in guinea pig ileum: blockade by alprenolol and dihydroalprenolol. J Pharmacol Exp Ther. 1990 Mar; 252(3):1034-42. PMID: 1969469.
      View in: PubMed
    59. Bond RA, Craig DA, Charlton KG, Ornstein AG, Clarke DE. Partial agonistic activity of GR43175 at the inhibitory prejunctional 5-HT1-like receptor in rat kidney. J Auton Pharmacol. 1989 Jun; 9(3):201-10. PMID: 2545718.
      View in: PubMed
    60. Bond RA, Ornstein AG, Clarke DE. Unsurmountable antagonism to 5-hydroxytryptamine in rat kidney results from pseudoirreversible inhibition rather than multiple receptors or allosteric receptor modulation. J Pharmacol Exp Ther. 1989 May; 249(2):401-10. PMID: 2724131.
      View in: PubMed
    61. Bond RA, Clarke DE. Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes. Br J Pharmacol. 1988 Nov; 95(3):723-34. PMID: 2905184; PMCID: PMC1854239.
    62. Bond RA, Clarke DE. A response to isoprenaline unrelated to alpha- and beta-adrenoceptor agonism. Br J Pharmacol. 1987 Jul; 91(3):683-6. PMID: 2886175; PMCID: PMC1853534.
    63. Bond RA, Charlton KG, Clarke DE. Evidence for a receptor mediated action of norepinephrine distinct from alpha- and beta-adrenoceptors. Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov; 334(3):261-6. PMID: 2880303.
      View in: PubMed
    64. Bond RA, Charlton KG, Clarke DE. Responses to norepinephrine resistant to inhibition by alpha and beta adrenoceptor antagonists. J Pharmacol Exp Ther. 1986 Feb; 236(2):408-15. PMID: 2868118.
      View in: PubMed
    65. Charlton KG, Bond RA, Clarke DE. An inhibitory prejunctional 5-HT1-like receptor in the isolated perfused rat kidney. Apparent distinction from the 5-HT1A, 5-HT1B and 5-HT1C subtypes. Naunyn Schmiedebergs Arch Pharmacol. 1986 Jan; 332(1):8-15. PMID: 3951568.
      View in: PubMed
    BOND's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _